Abstract:Background: Preeclampsia is a pregnancy-specific disease leading to maternal and perinatal morbidity. Hypertension and inflammation are the main characteristics of preeclampsia. Many factors can lead to hypertension and inflammation, including gut microbiota which plays an important role in hypertension and inflammation in humans. However, alterations to the gut microbiome and fecal metabolome, and their relationships in severe preeclampsia are not well known. This study aims to identify biomarkers significantly associated with severe preeclampsia and provide a knowledge base for treatments regulating the gut microbiome. Methods: In this study, fecal samples were collected from individuals with severe preeclampsia and healthy controls for shotgun metagenomic sequencing to evaluate changes in gut microbiota composition. Quantitative polymerase chain reaction analysis was used to validate the reliability of our shotgun metagenomic sequencing results. Additionally, untargeted metabolomics analysis was performed to measure fecal metabolome concentrations. Results: We identified several Lactobacillaceae that were significantly enriched in the gut of healthy controls, including Limosilactobacillus fermentum, the key biomarker distinguishing severe preeclampsia from healthy controls. Limosilactobacillus fermentum was significantly associated with shifts in KEGG Orthology (KO) genes and KEGG pathways of the gut microbiome in severe preeclampsia, such as flagellar assembly. Untargeted fecal metabolome analysis found that severe preeclampsia had higher concentrations of Phenylpropanoate and Agmatine. Increased concentrations of Phenylpropanoate and Agmatine were associated with the abundance of Limosilactobacillus fermentum. Furthermore, all metabolites with higher abundances in healthy controls were enriched in the arginine and proline metabolism pathway. Conclusion: Our research indicates that changes in metabolites, possibly due to the gut microbe Limosilactobacillus fermentum, can contribute to the development of severe preeclampsia. This study provides insights into the interaction between gut microbiome and fecal metabolites and offers a basis for improving severe preeclampsia by modulating the gut microbiome.

Ecological change of the gut microbiota during pregnancy and progression to dyslipidemia

The Role of Microbiomes in Pregnant Women and Offspring: Research Progress of Recent Years

Dynamics of the Gut Microbiota and Faecal and Serum Metabolomes during Pregnancy—A Longitudinal Study

Dynamic alteration in the gut microbiota and metabolome during the pregnancy

Dynamic changes in gut microbiota during pregnancy among Chinese women and influencing factors: A prospective cohort study

16S rRNA Gene Sequencing Revealed Changes in Gut Microbiota Composition during Pregnancy and Lactation in Mice Model

Dynamic changes in the gut microbiota during three consecutive trimesters of pregnancy and their correlation with abnormal glucose and lipid metabolism

Landscape of the gut mycobiome dynamics during pregnancy and its relationship with host metabolism and pregnancy health

Changes in Intestinal Microflora in Digestive Tract Diseases During Pregnancy

Gut microbiome interacts with pregnancy hormone metabolites in gestational diabetes mellitus

The interplay between the gut microbiota and metabolism during the third trimester of pregnancy

Multi-omics analysis reveals the associations between altered gut microbiota, metabolites, and cytokines during pregnancy

The impact of gut microbiota in full‐term pregnant women on immune regulation during pregnancy: A prospective, exploratory study

Gut Dysbiosis Promotes Preeclampsia by Regulating Macrophages and Trophoblasts

The Gut Microbiome Dynamically Associates with Host Glucose Metabolism throughout Pregnancy: Longitudinal Findings from a Matched Case‐Control Study of Gestational Diabetes Mellitus

Systematic analysis of gut microbiota in pregnant women and its correlations with individual heterogeneity

Landscapes of gut bacterial and fecal metabolic signatures and their relationship in severe preeclampsia

Deep metagenomic characterization of gut microbial community and function in preeclampsia

Gut microbiota changes in preeclampsia, abnormal placental growth and healthy pregnant women

Defective Atg16l1 in intestinal epithelial cells links to altered fecal microbiota and metabolic shifts during pregnancy in mice

Remodeling of the Gut Microbiota and Structural Shifts in Preeclampsia Patients in South China